CareCloud Increases 2025 Revenue Guidance Following Medsphere Acquisition
Rhea-AI Summary
CareCloud (NASDAQ: CCLD) has raised its 2025 revenue guidance following the acquisition of Medsphere Systems Corporation's business assets. The company now projects 2025 revenue of $116-118 million, up from the previous guidance of $111-114 million. For 2026, CareCloud anticipates revenue of $128-130 million.
The improved outlook reflects increased scale and expanded participation in the hospital IT market, with growth driven by cross-selling opportunities, expanded hospital adoption, and continued AI innovation. While Adjusted EBITDA guidance remains unchanged, GAAP EPS will be impacted by higher non-cash amortization expense from the acquisition.
Positive
- Increased 2025 revenue guidance by approximately $4-5 million
- Projected 2026 revenue growth to $128-130 million
- Expanded market presence through Medsphere acquisition
- Cross-selling opportunities and expanded hospital adoption potential
- Continued investment in AI innovation and automation
Negative
- Higher non-cash amortization expense will impact GAAP EPS
- Integration costs and challenges from Medsphere acquisition
News Market Reaction
On the day this news was published, CCLD declined 4.17%, reflecting a moderate negative market reaction. This price movement removed approximately $7M from the company's valuation, bringing the market cap to $163M at that time.
Data tracked by StockTitan Argus on the day of publication.
Company Raises 2025 Revenue Outlook to
SOMERSET, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions for hospitals and medical practices nationwide, today announced updated financial guidance following the August 22, 2025 closing of its acquisition of the business assets of Medsphere Systems Corporation (“Medsphere”).
For the full year 2025, CareCloud now expects revenue in the range of
“This increase in revenue guidance underscores the strong momentum generated by our transformative acquisition of Medsphere and the market demand we are seeing across our expanded product portfolio,” said Stephen Snyder, Co-Chief Executive Officer of CareCloud. “We are excited by the opportunities ahead as we bring CareCloud’s AI-driven solutions to both ambulatory and inpatient providers nationwide.”
“Our AI Center of Excellence is rapidly advancing tools that automate revenue cycle workflows and support clinicians in real time,” said A. Hadi Chaudhry, Co-Chief Executive Officer of CareCloud. “These innovations are designed to improve efficiency, strengthen financial performance, and enhance patient outcomes across the care continuum.”
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ
What is CareCloud's new revenue guidance for 2025 after the Medsphere acquisition?
How much revenue does CareCloud expect to generate in 2026?
Will the Medsphere acquisition affect CareCloud's EBITDA and EPS?
What are the main growth drivers for CareCloud following the Medsphere acquisition?
When did CareCloud complete the Medsphere acquisition?
